Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Closing the Gap in Care in Seronegative Inflammatory Arthritis [NA]
The trial on seronegative inflammatory arthritis sponsored by Pope Research Corporation has completed. It addresses care gaps for spondyloar…
-
CLINICAL_TRIALS withdrawal · 2017-04-07Clinical Trial Update: Psoriatic Arthritis Treat to Target vs. Usual Care [NA]
A clinical trial evaluating a treat-to-target approach versus usual care for psoriatic arthritis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions [Phase 1]
A Phase 1 parallel bioavailability study evaluating Leflunomide 20 mg tablets under fasting conditions. The trial, sponsored by Sandoz, is c…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis [Phase 3]
A Phase 3 study of an increased dose of TA-650 in patients with plaque psoriasis and related psoriatic conditions has completed, with result…
-
FDA approval · 2017-03-07FDA Approved: METHOTREXATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for METHOTREXATE SODIUM from Fresenius Kabi USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-03-06Clinical Trial Update: Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα [Phase 3]
A Phase 3 trial evaluating antiviral prophylaxis for HBsAg-positive or HBcAb-positive/HBsAb-negative patients starting anti-TNF therapy has …
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers [Phase 1]
A multicenter Phase 1 postmarketing study evaluating the concentration of certolizumab pegol (Cimzia) in mature breast milk of lactating mot…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis [Phase 2]
A Phase II study evaluating AbGn-168H for efficacy and safety in active psoriatic arthritis has completed.
-
FDA approval · 2017-01-11FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)
The FDA approved a supplemental application for OTREXUP (methotrexate) filed by Antares Pharma, Inc. This update expands the regulatory auth…
-
FDA approval · 2016-12-20FDA Approved: TREXALL — Supplemental Application (Teva Women's Health, Inc.)
FDA approved a supplemental application for TREXALL (methotrexate) from Teva Women's Health, Inc.
-
CLINICAL_TRIALS research · 2016-11-11Clinical Trial Update: Comparation of Ultrasonic Imaging of Enthesopathy in Patients With Psoriatic Arthritis and Psoriasis
This clinical trial update compares ultrasonic imaging of enthesopathy in patients with psoriatic arthritis and psoriasis to assess imaging …
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
This clinical trial evaluated golimumab (Simponi) in adults with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The …
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: A Study of Ixekizumab in Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial update for ixekizumab in active psoriatic arthritis; trial completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: A Study of RO5310074 in Patients With Psoriatic Arthritis [Phase 1]
Phase 1 clinical trial update for RO5310074 in patients with psoriatic arthritis; the Phase 1 study has completed.
-
CLINICAL_TRIALS withdrawal · 2016-10-21Clinical Trial Update: Treatment With Apremilast in Patients With Psoriatic Arthritis [Phase 4]
A Phase 4 trial of Apremilast for psoriatic arthritis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics
Clinical trial update for participants with psoriatic arthritis attending dermatology clinics. The study has completed.
-
CLINICAL_TRIALS research · 2016-09-01Clinical Trial Update: C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France
The C.O.R.P.U.S. observational cohort study of adult and child inflammatory arthritis in France has completed.
-
FDA approval · 2016-06-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) to Cordavis Limited, authorizing the continued manufacturing/supply of the p…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Distal Erosions and Nail Psoriasis
This is a clinical trial update on distal erosions and nail psoriasis in psoriatic arthritis, sponsored by Hospices Civils de Lyon; the tria…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 [Phase 2]
This clinical trial update notes that the Phase 2 open-label extension of ABT-122 in active psoriatic arthritis subjects who completed study…
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis [Phase 3]
A phase 3 safety and efficacy study of apremilast in psoriatic arthritis has completed with posted results.
-
CLINICAL_TRIALS research · 2016-05-27Clinical Trial Update: 99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity [Phase 2]
Phase 2 clinical trial evaluating 99mTc-anti-TNF-alpha scintigraphy for assessing inflammatory activity in psoriatic arthritis and arthritis…
-
EMA withdrawal · 2016-04-21EMA Withdrawn: Repso (leflunomide) — Teva B.V.
The EMA has withdrawn Repso (leflunomide) from the market, a disease-modifying antirheumatic drug previously used for rheumatoid arthritis a…
-
FDA approval · 2016-04-05FDA Approved: INFLECTRA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved INFLECTRA (infliximab-dyyb) as a biosimilar to infliximab for multiple autoimmune diseases, expanding access to a biologic ther…
-
FDA approval · 2016-02-29FDA Approved: LEFLUNOMIDE — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application for Leflunomide by Apotex Corp., approving this generic product.